MIRA Pharmaceuticals, Inc. (MIRA)
0.551
+0.01
(+2.00%)
USD |
NASDAQ |
Nov 06, 10:36
MIRA Pharmaceuticals Enterprise Value : 14.59M for Nov. 5, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 05, 2026 | 14.59M |
| November 04, 2026 | 15.46M |
| November 03, 2026 | 13.65M |
| November 02, 2026 | 14.46M |
| October 30, 2026 | 14.94M |
| October 29, 2026 | 15.91M |
| October 28, 2026 | 15.26M |
| October 27, 2026 | 15.00M |
| October 26, 2026 | 14.28M |
| October 23, 2026 | 17.92M |
| October 22, 2026 | 18.31M |
| October 21, 2026 | 20.54M |
| October 20, 2026 | 19.21M |
| October 19, 2026 | 18.87M |
| October 16, 2026 | 18.46M |
| October 15, 2026 | 19.54M |
| October 14, 2026 | 20.55M |
| October 13, 2026 | 19.89M |
| October 12, 2026 | 21.53M |
| October 09, 2026 | 23.21M |
| October 08, 2026 | 21.43M |
| October 07, 2026 | 21.72M |
| October 06, 2026 | 21.80M |
| October 05, 2026 | 22.79M |
| October 02, 2026 | 22.57M |
| Date | Value |
|---|---|
| October 01, 2026 | 22.27M |
| September 30, 2026 | 27.39M |
| September 29, 2026 | 28.51M |
| September 28, 2026 | 29.85M |
| September 25, 2026 | 29.71M |
| September 24, 2026 | 27.16M |
| September 23, 2026 | 27.93M |
| September 22, 2026 | 29.96M |
| September 21, 2026 | 28.82M |
| September 18, 2026 | 26.86M |
| September 17, 2026 | 23.79M |
| September 16, 2026 | 22.13M |
| September 15, 2026 | 21.89M |
| September 14, 2026 | 23.51M |
| September 11, 2026 | 24.40M |
| September 10, 2026 | 25.05M |
| September 09, 2026 | 24.68M |
| September 08, 2026 | 24.49M |
| September 04, 2026 | 23.98M |
| September 03, 2026 | 22.97M |
| September 02, 2026 | 27.58M |
| September 01, 2026 | 28.03M |
| August 31, 2026 | 24.25M |
| August 28, 2026 | 23.41M |
| August 27, 2026 | 24.25M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Resonate Blends, Inc. | 5.781M |
| Breakthrough Chemistry, Inc. | 0.2143M |
| Kaya Holdings, Inc. | -- |
| Cardiac Biotech Solutions, Inc. | 6.406M |
| Real Brands, Inc. | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.208M |
| Total Expenses (Quarterly) | 1.208M |
| EPS Diluted (Quarterly) | -0.0288 |
| Earnings Yield | -249.8% |
| Normalized Earnings Yield | -249.75 |